ERYTECH annonce le recrutement du premier patient dans une étude de phase 1 conduite par un investigateur avec eryaspase dans le traitement de première ligne du cancer du pancréas

NEXT STORY
Eldorado Provides 2021 Guidance and Five-Year Outlook; Announces Management Appointments
PREV STORY
Relay Medical and Glow LifeTech Report on Successful Phase II Clinical Results For COVID-19 Treatment Candidate Based On Its MyCell Technology™
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Global COVID-19 Vaccines Industry

author_avatar
NASDAQ Market News

Agios Highlights Key 2019 Initiatives to Broaden Potential for Cancer and Rare Genetic Disease Programs to Build Long-Term Value

– Expanding the Label for TIBSOVO®: Supplemental New Drug Application (sNDA) Submitted for TIBSOVO® ...

author_avatar
NASDAQ Market News

CloudMedx Working With UCSF to Deploy AI Tools to Support the Management of Liver Cancer Patients Awaiting Liver Transplant

PALO ALTO, Calif., Aug. 02, 2018 (GLOBE NEWSWIRE) -- CloudMedx, a healthcare AI company ...

author_avatar
NASDAQ Market News